A monthly pharma newsletter from consultancy Galenisys mixing first-person war stories from GMP auditing and quality work with short pieces on industry trends such as GLP-1 drugs and orexins. Readers get practical quality, contamination control and project management lessons alongside light market commentary.

Chivanta is a weekly Chinese-language newsletter by a former biotech industry professional who analyses the business side of life sciences, including business development, licensing, CDMO operations and market strategy. Recent issues mix practical lessons from industry work, such as backing research from market needs and estimating GMP manufacturing timelines and costs, with personal reflections.

An independent analytical research newsletter that examines pharmaceutical open innovation, business development, M&A and corporate venture activity, using deal-level data and balance-sheet analysis. Recent issues dissect the external growth strategies of AstraZeneca, Eli Lilly and Novo Nordisk.

Molecules & Empires examines how scientific breakthroughs such as AI-driven drug discovery, embryo gene editing and outbreak response reshape industries, economies and power. Its issues combine news hooks with analytical essays that weigh business strategy, ethics and science policy.